Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?

AIM: Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a lack of evidence whether patients with myocarditis and impaired LVEF may benefit from treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaschke, Florian, Lacour, Philipp, Dang, Phi Long, Parwani, Abdul Shokor, Hohendanner, Felix, Walter, Thula, Klingel, Karin, Kühl, Uwe, Heinzel, Frank R., Sherif, Mohammad, Boldt, Leif‐Hendrik, Pieske, Burkert, Tschöpe, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318471/
https://www.ncbi.nlm.nih.gov/pubmed/33932118
http://dx.doi.org/10.1002/ehf2.13340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318471/
https://www.ncbi.nlm.nih.gov/pubmed/33932118
http://dx.doi.org/10.1002/ehf2.13340

Ejemplares similares